ChenowethD.E., CheungA.K., HendersonL.W.Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes. Kidney Int1975; 24: 764–9.
26.
HendersonL.W., MillerM.E., HamiltonR.W., NormanM.E.Hemodialysis leukopenia and polymorph random mobility — a possible correlation. J Lab Clin Med1985; 85: 191–7.
27.
AljamaP., BirdD.A.E., WardM.K., FeestT.G., WalkerW., TanbogaH.Hemodialysis-induced leucopenia and activation of complement. Effects of different membranes. Proc Eur Dial Transplant Assoc1978; 15: 144–53.
28.
JacobA.J., GavellasG., ZarcoR., PerezG., BourgoignieJ.J.Leukopenia, hypoxia and complement function with different hemodialysis membranes. Kidney Int1980; 18: 505–9.
29.
IvanovichP., ChenowethD.E., SchmidtR.Symptoms and activation of granulocytes and complement with two dialysis membranes. Kidney Int1983; 24: 758–63.
30.
AmadoriA., CandiP., SasdelliM.Hemodialysis leukopenia and complement function with different dialyzers. Kidney Int1983; 24: 775–81.
31.
HakimR.M., FearonD.T., LazarusJ.M.Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int1984; 26: 194–200.
32.
VanherweghemJ.L., GoldmanM., GamarN., LietarN., ThayseC.Hypoxemia, leukopenia and complement activation with large surface hemodialyzers: comparison of cellulose acetate with cuprophan. In: SmebyLC. Immune and metabolic aspects of therapeutic blood purification systems.Basel: Karger, 1986, 85–91.
33.
AljamaP., Martin-MaloA., CastilloD.Anaphylatoxin Csa generation and dialysis-induced leukopenia with different hemodialyzer membranes. Blood Purific1986; 4: 88–92.
34.
SmebyL.C., WideroeT.E., BalstadT., JorstadS.Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers. Blood Purific1986; 4: 93–101.
35.
NotohamiprodjuM., AndrassyK., BommerJ., KirschfinkM., RotherU., RitzE.Different in vitro generation of C3d by cepramonium and polycarbonate capillary hemodialyzers. Nephron1986; 43: 254–7.
36.
CheungA.K., HendersonL.W.Effects of complement activation by hemodialysis membranes. Am J Nephrol1986; 9: 81–91.
37.
ChenowethD.E., CheungA.K., WardD.M., HendersonL.W.Anaphylatoxin function during hemodialysis. Comparison of new and reused dialyzers. Kidney Int1983; 24: 770–4.
38.
LevettD.L., WoffindinC., BirdA.G., HoenichN.A., WardN.K., KerrD.N.S.Complement activation in hemodialysis: a comparison of new and reused dialyzers. Int J Artif Organs1986; 9: 97–104.
39.
CheungA.K., ChenowethD.E., OtsukaD., HendersonL.W.Compartimental distribution of complement activation products in artificial kidneys. Kidney Int1986; 30: 74–80.
40.
HoenichN.A., JohnstonS.R.D., WoffindinC., KerrD.N.S.Hemodialyzers leucopenia: the role of membrane type and re-use. Contr Nephrol1984; 37: 120–8.
41.
ChenowethD.E.Complement activation during hemodialysis: clinical observations, proposed mechanisms and theorical implications. Artif Organs1984; 8: 281–7.
42.
GoldmanM., LietarN., LambertP., ThayseC., VanherweghemJ.L.Complement activation and leucopenia on cellulosic hemodialysis: influence of the membrane area and role of hydroxyl moieties (in press). (Life Support Systems).
43.
CarrenoM.P., LabarreD., KazatchkineM.D., JozefowiczM.Interactions between polysaccharides derivatives and the complement system. Life Support Systems1986: 4 (suppl 2): 198–200.
44.
CraddockP.R., HammerschmidtD.E., WhiteJ.G., DalmassoA.P., JacobH.S.Complement (C5a)-induced granulocyte aggregation in vitro: a possible mechanism for complement-mediated leukostasis and leukopenia. J Clin Invest1977; 60: 260–4.
45.
WebsterR.O., LarsenG.L., HensonP.M.In vivo clearance and tissue distribution of C5a and C5a desarg complement fragments in rabbits. J Clin Invest1982; 70: 1177–83.
46.
ChenowethD.E., HugliT.E.Demonstration of a specific C5a receptor on intact human polymorphonuclear leukocytes. Proc. Natl Acad Sci USA1978; 75: 3943–7.
47.
ArnaoutM.A., HakimR.M., ToddR.F.III, DanaN., ColtenH.R.Increase expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med1985; 312: 457–62.
48.
NguyenA.T., LethiasC., ZingraffJ., HerbelinA., NaretC., Descamps-LatschaB.Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microammounts of whole blood. Kidney Int1985; 28: 158–67.
49.
RitcheyE.E., WallinJ.D., ShahS.V.Chemoluminescence and superoxide anion production by leukocytes from chronic hemodialysis patients. Kidney Int1981; 19: 349–58.
50.
GreeneW.H., CasannR.S., MauerM., QuieP.The effect of hemodialysis on neutrophilic chemotactic responsiveness. J Lab Clin Med1986; 88: 971–4.
51.
Lespier-DexterL.E., GuerraC., OjedaW., Martinez-Maldo-nadoM.Granulocyte-adherence in uremia and hemodialysis. Nephron1979; 24: 64–8.
52.
Mac GregorR.R.Granulocyte adherence changes induced by hemodialysis, endotoxin, epinephrin and glucocorticoids. Ann Intern Med1977; 86: 35–9.
53.
HallgrenR., FjellstromK.E., HakanssonL., VengeP.Kinetic studies of phagocytosis II. The serum-independent uptake of IgG-coated particles by polymorphonuclear leukocytes from uremic patients on regular dialysis treatment. J Lab Clin Med1979; 94: 277–84.
54.
WingA.J., BrunnerF.P., BryngerH.A.Mortality and morbidity of reusing dialyzers. Br Med J1978; 2: 853–5.
55.
KantsK.S., PollakV.E., CatheyM., GoetzD., BerlinR.Multiple use of dialyzers. Safety and efficacy. Kidney Int1981; 19: 728–38.
56.
ChanardJ., BrundisJ.P., MelinJ.P., LavaudS., ToupanceO.Long term results of dialysis therapy with a highly permeable membrane. Artificial Organs1982; 6: 261–6.
57.
WaterlotY., CantinieauxB., HarigaC., De MartelaereE., VanherweghemJ.L., FonduP.Impaired phagocytic activity of neutrophils in patients receiving hemodialysis: the critical role of iron overload. Br Med J1985; 291: 501–4.
58.
FlamentJ., GoldmanM., WaterlotY., DupontE., WybranJ., VanherweghemJ.L.Impairment of phagocyte oxidative metabolism in hemodialyzed patients with iron overload. Clin Nephrol1986; 25: 227–30.
59.
HorlW.H., JochumM., HeidlandA., FritzH.Release of granulocyte proteinases during hemodialysis. Am J Nephrol1983; 3: 213–7.
60.
SchaeperR.M., HeidlandA., HorlW.H.Release of leucocyte elastase during hemodialysis. Effect of different dialysis membranes. Contr Nephrol1985; 46: 109–17.
61.
HorlW.H., Stein-HauerH.B., SchollmeyerP.Plasma levels of granulocyte elastase during hemodialysis. Effect of different dialyzer membranes. Kidney Int1985; 28: 791–6.
62.
KnudsenF., NielsenA.H., PedersenJ.D.Leukopenia and release of granulocyte elastase: interlinked membrane dependent event during hemodialysis. Blood Purif1984; 2: 36–40.
63.
KnudsenF., NielsenA.H., PedersenJ.O., GrunnetN., Jer-sildC.Adult respiratory distress like syndrome during hemodialysis: relationship between activation of complement, leukopenia and release of granulocyte elastase. Int J Artif Organs1985; 8: 187–94.
64.
SherlockJ.E., YoonY., LedwithJ.W., LetteriJ.M.Respiratory gas exchange during hemodialysis. Proc Dial Transplant Forum, 1972; 2: 171–4.
65.
BischelM.D., OrrelF.L., ScolesB.G., MohlerJ.G., BarbourB.H.Effects of microemboli blood filtration during hemo-diadialysis. Trans Am Soc Artif Intern Organs1973; 19: 492–7.
66.
BischelM.D., ScolesB.F., MohlerT.F.Evidence for pulmonary microembolization during hemodialysis. Chest1975; 67: 335–7.
67.
TolchinN., RobertsJ.L., LewisE.J.Respiratory gas exchange by high efficiency hemodialyzers. Nephron1978; 21: 137–45.
68.
VaziriN.D.Dialysis-induced hypoxemia. Int J Artif Organs1982; 5: 8–10.
69.
CarlonG.C., CampfieldP.B., GoldinerP.L., TurnbullA.D.Hypoxemia during hemodialysis. Critical Care Med1979; 7: 497–9.
70.
FountainS.W., MartinB.A., MusclowL.E., CooperJ.D.Pulmonary leukostasis and its relationship to pulmonary dysfunction in sheep and rabbits. Circ Res1980; 46: 175–80.
71.
HakimR.M., LowrieE.G.Hemodialysis associated neutropenia and hypoxemia: the effect of dialyzer membrane materials. Nephron1982; 32: 32–9.
72.
SherlockJ.J., LedwithJ.W., LetteriJ.Hypoventilation and hypoxemia during hemodialysis: reflex response to removal of CO2 across the dialyzer. Trans Am Soc Artif Intern Organs1977; 23: 406–10.
73.
AurigemmaN.M., FeldmanN.T., GotliebM., IngramR.H., LazarusJ.M., LowrieE.G.Arterial oxygenation during hemodialysis. N Engl J Med1977; 297: 871–3.
74.
PattersonR.W., NissensonA.R., MillerJ., SmithR.T., NarinsR.G., SullivanS.F.Hypoxemia and pulmonary gas exchange during hemodialysis. J Appl Physiol Respir Environ Exercice Physiol1981; 50: 259–64.
75.
DolanM.J., WhippB.J., DavidsonW.D., WeitzmanR.E., Was-sermanK.Hypopnea associated with acetate hemodialysis: carbon dioxide-flow dependent ventilation. N Engl J Med1981; 305: 72–5.
RomaldiniH., Rodriguez-RoisinR., LopezF.A., ZieglerT.W., BencowitzH.Z., WagnerP.D.The mechanisms of arterial hypoxemia during hemodialysis. Ann Rev Respir Dis1984; 129: 780–4.
78.
DulmerF., LevinN.W.Leukopenia and hypoxemia: unrelated effects of hemodialysis. Arch Intern Med1979; 139: 1103–6.
79.
GarellaS., ChangB.S.Hemodialysis associated hypoxemia. Am J Nephrol1984; 4: 273–9.
80.
JacobA.J., GavellasG., ZarcoR., BerezG., BourgoignieJ.J.Leukopenia, hypoxemia and complement function with different hemodialysis membranes. Kidney Int1980; 18: 505–9.
81.
MahajanS., GardinerH., DetarB.Relationship between pulmonary functions and hemodialysis induced leukopenia?Trans Am Soc Intern Artif Organs1977; 23: 411–4.
82.
WalkerJ.F., LindsayR.M., PetersS.D., SibbaldW.J., LintonA.L.A sheep model to examine the cardiopulmonary manifestations of blood dialyzer interaction. Am Soc Artif Intern Organs1983; 6: 123–30.
83.
WalkerJ.F., LindsayR.M., SibbaldW.J., LintonA.L.Acute pulmonary hypertension, leucopenia and hypoxia in early dialysis. Proc Eur Dial Transplant Assoc1984; 21: 135–42.
84.
WalkerJ.F., LindsayR., SibbaldW., LintonA.L.Changes in pulmonary vascular tone during early hemodialysis. Trans Am Soc Artif Intern Organs1984; 30: 168–72.
85.
NissensonA.R.Prevention of dialysis induced hypoxemia by bicarbonate dialysis. Trans Am Soc Artif Intern Organs1980; 26: 339–41.
86.
EiserA.R., JayamanneD., KoksengC., CheH., SlifkinR.F., NeffM.S.Contrasting alterations in pulmonary gas exchange during acetate and bicarbonate hemodialysis. Am J Neprhol1982; 2: 123–7.
87.
IgarashiH., KioiS.Gejyo F, Arakawa M. Physiologic approach to dialysis-induced hypoxemia. Effect of dialyzer material and dialysate composition Nephron1985; 41: 62–9.
88.
SerranoR.P., VegaF.F., GrandeJ.A.Hypoxemia during hemodialysis in patients with impairment in pulmonary function. Nephron1986; 42: 14–8.
89.
KrautJ.Gafter V, Brautbar N, Miller J, Shinaberger J. Prevention of hypoxemia during dialysis by the use of sequential isolated ultrafiltration-diffusion dialysis with bicarbonate dialysate. Clin Nephrol1981; 15: 181–4.
90.
RalphD.D., OttS.M., SherrardD.J., HlastalaM.D.Inert gas analysis of ventilation-perfusion matching during hemodialysis. J Clin Invest1984; 73: 1385–91.
91.
BouffardY., VialeJ.P., AnnatG.Pulmonary gas exchange during hemodialysis. Kidney Int1986; 30: 920–3.
92.
JonesR.H., BroadfieldJ.B., ParsonsV.Arterial hypoxemia during hemodialysis for acute renal failure in mechanically ventilated patients: observations and mechanisms. Clin Nephrol1980; 14: 18–22.
93.
De BackerW.A., VerpootenG.A., BorgojonD.J., VermeireP.A., LinsR.R., De BroeM.E.Hypoxemia during hemodialysis: effects of different membranes and dialysate compositions. Kidney Int1983; 23: 738–43.
94.
FrancosG.C., BesarabA., BurkeJ.F.Dialysis-induced hypoxemia: membrane dependant and membrane independant causes. Am J Kidney Dis1985; 5: 191–8.
95.
VaziriN.D., WilsonA., MukaiD.Dialysis hypoxemia: role of dialyzer membrane and dialysate delivery system. Am J Med1984: 77: 828–33.
96.
HakimR.M., BreillatJ., LazarusJ.M., PortH.K.Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med1984; 311: 878–82.
97.
OgdenD.A.New dialyzer syndrome. N Engl J Med1980; 302: 1262.
AgarJ.W., HullJ.D., KaplanM., PletkaP.F.Acute cardiopulmonary decompensation and complement activation during hemodialysis. Ann Intern Med1979; 90: 792–3.
100.
PopliS., IngT.S., DaugirdasJT. Severe reactions to cuprophan capillary dialyzers. Artif Organs1982; 6: 312–5.
101.
NichollsA.J., PlattsM.M.Anaphylactoid reactions due to hemodialysis, hemofiltration or membrane plasma separation. Br Med J1982; 285: 1607–9.
102.
KeyJ., NahmiasM., AcchiardoS.Hypersensitivity reaction on first time exposure to cuprophane hollow fiber dialyzer. Am J Kidney Dis1983; 2: 664–6.
103.
StephensG.W., BernardD.B., IdelsonB.A.Anaphylaxis: an unusual complication of hemodialysis. Clin Nephrol1985; 24: 95–102.
104.
IngT.S., DaugirdasJ.T., PopliS., GhandiV.C.First use syndrome with cuprammonium cellulose dialyzers. Int J Artif Organs1983; 6: 235–9.
105.
FoleyR.S., ReevesW.B.Acute anaphylactoid reactions in hemodialysis. Am J Kidney Dis1985; 5: 132–5.
106.
BokD.V., PascualL., HebergerC., SawyerR., LevinN.W.Effect of multiple use of dialyzers on intradialytic symptoms. Proc Dial Transplant Forum1980; 10: 92–9.
107.
VillarroelF., CiarkowskiA.A.A survey on hypersensitivity reactions in hemodialysis. Artif Organs1985; 9: 231–8.
108.
RaultR., SilverM.R.Severe reactions during hemodialysis. Am J Kidney Dis1985; 5: 128–31.
109.
VillaroelF.Incidence of hypersensitivity in hemodialysis: report by the FDA. Artif Organs1984; 8: 278–80.
110.
FrantJ.A., DupreeE., GoldmanA.S., SchultzD.R., JacksonA.L.Complement-mediated release of histamine from human leukocytes. J Immunol1975; 114: 1101–6.
111.
PetersonM.B., HuttemeierP.C., ZapolW.M., MartinE.G., WatkinsW.D.Thromboxane mediates acute pulmonary hypertension in sheep extracorporeal perfusion. Am J Physiol1982; 243: H471–H479.
112.
HakimR.M., SchaferA.I.Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med1985; 78: 575–80.
113.
PoothullilJ., ShimizuA., DayR.P., DolovichJ.Anaphylaxis for the product(s) of ethylene oxide gas. Ann Intern Med1975; 82: 58–60.
114.
DolovichJ., BellB.Allergy to a product(s) of ethylene oxide gas: demonstration of IgE and IgG antibodies and hapten specificity. J Allergy Clin Immunol1978; 62: 30–2.
115.
DolovichJ., MarshallC.P., EkmSmith. Allergy to ethylene oxide in chronic hemodialysis patients. Artif Organs1984; 8: 334–7.
116.
MarshallC.P., PearsonF.C., SagonaM.A.Reactions during hemodialysis caused by allergy to ethylene oxide gas sterilization. J Allergy Clin Immunol1985; 75: 563–7.
117.
NichollsA.J., PlattsM.M.Anaphylactoid reactions during hemodialysis are due to ethylene oxide hypersensitivity. Proc Eur Dial Transplant Assoc1984; 21: 173–7.
118.
GrammerL.C., ShaughnessyM.A., PattersonB.F., PattersonR.Characterizations of an antigen in acute anaphylactic dialysis reactions: ethylene oxide-altered human serum albumin. J Allergy Clin Immunol1985; 76: 670–5.
119.
RockelA., ThielC., AbdelhamidS., FiegelP., WalbD.The cases of hemodialysis-associated hypersensitivity reactions. Int J Artif Organs1985; 8: 179–80.
120.
CaruanaR.J., HamiltonR.W., PearsonF.C.Dialyzer hypersensitivity syndrome: possible role of allergy to ethylene oxide. Report of 4 cases and review of the literature. Am J Nephrol1985; 5: 271–4.
121.
GrammerL.C., PattersonB.F., RoxeD.IgE against ethylene oxide altered human serum albumin in patients with anaphylactic reactions to dialysis. J Allergy Clin Immunol1985; 76: 511–4.
122.
HoyW.E., CesteroR.U.M.Eosinophilia in maintenance hemodialysis patients. J Dialysis1979; 3: 73–87.
123.
MontoliuJ., Lopez-PedretJ., AndreuL., RevertL.Eosinophilia in patients undergoing dialysis. Br Med J1981; 282: 2098.
124.
SpinowitzR.S., SimpsonM., ManuP., CharytanC.Dialysis eosinophilia. Trans Am Soc Artif Intern Organs1981; 27: 161–7.
125.
DratwaM., TielemansC., BrenezD.IgE levels in patients with chronic renal failure. N Engl J Med1981; 305: 960–1.
DinarelloC.A.The biology of interleukin-1 and its relevance to hemodialysis. Blood Purif1983; 1: 197–224.
133.
BingelM., LonnemannG., ShaldonS., KochK.M., DinarelloC.A.Human interleukin-1 production during hemodialysis. Nephron1986; 43: 161–3.
134.
FaveroM.S., PetersenN.J., BoyerK.M., CarsonL.A., BondV.W.Microbial contamination of renal dialysis systems and associated health risks. Trans Am Soc Artif Intern Organs1974; 20: 175–83.
135.
BernickJ.J., PortF.K., FaveroM.S., BrownD.G.Bacterial and endotoxin permeability of hemodialysis membranes. Kidney Int1979; 16: 491–6.
136.
BahuerH., BrunnerH., FranzI.E., BueltmannB.Leucocyte function tests during hemodialysis with different membranes. Contr Nephrol1983; 36: 9–14.
137.
GoodmanM.G., ChenowethD.E., WeigleW.O.Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface. J Exp Med1982; 156: 912–7.
138.
GiacchinoF., PozzatoM., LandolfoS.Interleukin 1 in hypersensitivity reaction during hemodialysis. Proc Eur Dial Transplant Assoc1985; 22: 192–5.
139.
GoldmanM., SchandeneL., VandervorstP., BraudG., VanherweghemJ.L.Impairment in the capability to release interleukin-1 and interleukin-2 in the early phase of hemodialysis. Life Supports System1986; 4(suppl 2): 252–4.
140.
BaracosV., RodemannH.P., DinarelloC.A., GoldbergA.L.Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1): a mechanism for the increased degradation of muscle protein during fever. N Engl J Med1983; 308: 553–8.
141.
BergstromJ., AlvestrandA., GutierrezA.Acute and chronic metabolic effects of hemodialysis. In: SmebyLC. Immune and metabolic aspects of therapeutic blood purification systems.Basel: Karger, 1986: 254–73.
BommerJ., RitzE., WaldherrR., GastnerM.Silicone cell inclusions causing multiorgan foreign body reaction in dialyzed patients. Lancet1981; i: 1314.
144.
BommerJ., RitzE., WaldherrR.Silicone induced splenomegaly. Treatment of pancytopenia by splenectomy in a patient on hemodialysis N Engl J Med1981; 305: 1077–9.
145.
ParfreyP.S., O'DriscollJ.B., ParadinasG.J.Refractile material in the liver of hemodialysis patients. Lancet1981; i: 889–90.
146.
LeongA.S.Y., DisneyA.P.C., GoveD.W.Spallation and migration of silicone from blood-pump tubing in patients on hemodialysis. N Engl J Med1982; 306: 135–40.
147.
LaohapandT., MorleyA.R., WardM.K., KerrD.N.S.Accumulation of silicone elastomers in patients on regular hemodyalisis. Proc Eur Dial Transplant Ass1982; 19: 143–52.
148.
MoralesJ.M., ColinaF., AtegaJ.Clinical implications of the presence of refractile particles in the liver of hemodialysis patients. Proc Eur Dial Transplant Ass1982; 19: 265–9.
149.
BourbigotB., BuzelinF., FontenailleC., DubigeonP., Mussini-MontpellierJ.Dépôts de silicone dans les macrophages chez les patients en hemodialyse chronique. Nephrologie1983; 4: 123–8.
150.
BommerJ., WaldherrR., RitzE.Silicone storage in long term hemodialysis patients. Contr Nephrol1983; 36: 115–26.
151.
BommerJ., RitzE.Spallation of dialysis material. Problems and prospectives (Editorial). Nephron1985; 39: 285–9.
152.
BommerJ., GemsaO., WaldherrR., KesslerJ., RitzE.Plastic filing from dialysis tubing induces prostanoid release from macrophages. Kidney Int1984; 26: 331–7.
153.
BommerJ., GemsaO., KesslerJ., RitzE.Evidence for macrophage activation in dialysis patients exposed to silicone filing. Nephron1985; 39: 395–7.
154.
WarrenD.J., OtienoL.S.Carpal tunnel syndrome in patients on intermittent hemodialysis. Postgrad Med J1975; 51: 450–2.
AllieuY., AsencioG., MailheD., BaldetP., MionC.Syndrome du canal carpien chez l'hémodialysé chronique. Approche etio-pathogénique. A propos de 31 cas opérés. Rev Chir Orthop1983; 69: 233–8.
160.
KachelH.G., AltmeyerP., BaldamusC.A., KochK.M.Deposition of an amyloid-like substance as a possible complication of regular dialysis treatment. Contr Nephrol1983; 36: 127–32.
161.
SpertiniF., WautersJ.P., PoulenasI.Carpal tunnel syndrome: a frequent, invalidating, long term complication of chronic hemodialysis. Clin Nephrol1984; 21: 98–101.
162.
SchwarzA., KellerF., SeyfertS., PollW., MolzahnM., DistlerA.Carpal tunnel syndrome: a major complication in long term hemodialysis patients. Clin Nephrol1984; 22: 133–7.
163.
CharraB., CalemardE., UzanM., TerratJ.G., VanelT., LaurentG.Carpal tunnel syndrome, shoulder pain and amyloid deposits in long term hemodialysis patients. Proc Eur Dial Transplant Assoc1984; 21: 291–5.
164.
WaltsA.E., GoodmanM.D., MatorinP.A.Amyloid carpal tunnel syndrome, and chronic hemodialysis. Am J Nephrol1985; 5: 225–6.
165.
HuauxJ.P., NoelH., BastienP.Amylose articulaire, fracture du col fémoral et hémodialyse périodique chronique. Rev Rhum1985; 52: 179–82.
166.
HerveJ.P., ClodesJ., BourbigotB.Systemic amyloidosis in the course of maintenance hemodialysis. Nephron1985; 40: 494.
Munoz-GomezJ., Bergada-BaradoE., Gomez-PerezR.Amyloid arthropathy in patients undergoing periodical hemodialysis for chronic renal failure: a new complication. Ann Rheum Dis1985; 44: 729–33.
169.
VandenbrouckeJ.M., HuauxJ.P., GuillaumeT., NoelH., MaldagueB., Van Yperselle De StrihouC.Capsular synovial and bone amyloidosis: complications of long term hemodialysis. Proc Eur Dial Transplant Assoc1985; 22: 136–8.
170.
HillionD., VilleboeufJ., HillionY., NakamuraA., BruetA.Appearance of systemic amyloidosis in a chronic hemodialysis patient. Nephron1985; 41: 127–8.
171.
DiraimondoC.R., CaseyT.T., DiraimondoC.V., StoneW.J.Pathologic fractures associated with idiopathic amyloidosis of bone in chronic hemodialysis patients. Nephron1986; 43: 22–7.
172.
KuntzD., NaveauB., BardinT., DruekeT., TrevesR., DryllA.Destructive spondylarthropathy in hemodialyzed patients: a new syndrome. Arthritis Rheum1984; 27: 369–75.
ShirahamaT., SkinnerM., CohenA.S.Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as Beta2 microglobulin. Lab Invest1985; 53: 705–9.
175.
GejyoF., OdaniS., YamadaT.Beta2 microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int1986; 30: 385–90.
176.
CaseyT.T., StoneW.J., DiraimondoC.R.Tumoral amyloidosis of bone of Beta2 microglobulin origin in association with long term hemodialysis: a new type of amyloid disease. Hum. Pathol1986; 17: 731–8.
177.
GorevicP.D., MunozP.C., CaseyT.T.Polymerization of intact Beta2 microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc Natl Acad Sci USA1986; 83: 7908–12.
VandenbrouckeJ.M., JadoulM., MaldagueB., HuauxJ.P., NoelH., Van Yperseele De StrihouC.Possible role of dialysis membrane characteristics in amyloid osteoarthropathy. Lancet1986; i: 1210–1.